Quarterly report · Q3

Period2023-01-21 → 2023-10-20
Filed2023-12-01
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥165.3bn2023-01-21 → 2023-10-20Cons.Net sales
Revenue¥160.1bn2022-01-21 → 2023-01-20Cons.Net sales (5-year summary)
Revenue¥124.6bn2022-01-21 → 2022-10-20Cons.Net sales
Operating income¥5.8bn2023-01-21 → 2023-10-20Cons.Operating income
Operating income¥2.3bn2022-01-21 → 2022-10-20Cons.Operating income
Ordinary income¥5.2bn2023-01-21 → 2023-10-20Cons.Ordinary income
Ordinary income¥591m2022-01-21 → 2023-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.6bn2022-01-21 → 2022-10-20Cons.Ordinary income
Profit before tax¥7.7bn2023-01-21 → 2023-10-20Cons.Income before income taxes
Profit before tax¥2.9bn2022-01-21 → 2022-10-20Cons.Income before income taxes
Net income (owners)¥4.2bn2023-01-21 → 2023-10-20Cons.Profit loss attributable to owners of parent
Net income (owners)−¥507m2022-01-21 → 2023-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥736m2022-01-21 → 2022-10-20Cons.Profit loss attributable to owners of parent
Net income¥4.5bn2023-01-21 → 2023-10-20Cons.Profit loss
Net income¥725m2022-01-21 → 2022-10-20Cons.Profit loss
Total assets¥185.6bnat 2023-10-20Cons.Assets
Total assets¥164.2bnat 2023-01-20Cons.Assets
Total assets¥167.8bnat 2022-10-20Cons.Total assets (5-year summary)
Total liabilities¥95.1bnat 2023-10-20Cons.Liabilities
Total liabilities¥80.1bnat 2023-01-20Cons.Liabilities
Net assets / equity¥90.5bnat 2023-10-20Cons.Net assets
Net assets / equity¥84.1bnat 2023-01-20Cons.Net assets
Net assets / equity¥84.1bnat 2022-10-20Cons.Net assets (5-year summary)
Cash and deposits¥32.8bnat 2023-10-20Cons.Cash and deposits
Cash and deposits¥27.2bnat 2023-01-20Cons.Cash and deposits
EPS (basic)¥266.092023-01-21 → 2023-10-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥116.782023-07-21 → 2023-10-20dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.42022-01-21 → 2023-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.992022-01-21 → 2022-10-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥102.452022-07-21 → 2022-10-20dCons.Basic earnings loss per share (5-year summary)
Equity ratio47.7%at 2023-10-20Cons.Equity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio49.9%at 2022-10-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-21 → 2023-10-20−¥313m
Reconciling Itemsreconcilingrevenue intersegment2023-01-21 → 2023-10-20−¥313m
Reconciling Itemsreconcilingsegment profit2023-01-21 → 2023-10-20−¥1.1bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue2023-01-21 → 2023-10-20¥118.0bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-10-20¥117.9bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2023-01-21 → 2023-10-20¥26m
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-10-20¥4.8bn
jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segmentsegment profit2023-01-21 → 2023-10-20−¥406m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue2023-01-21 → 2023-10-20¥17.1bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue external2023-01-21 → 2023-10-20¥17.1bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue intersegment2023-01-21 → 2023-10-20¥6m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentsegment profit2023-01-21 → 2023-10-20¥1.4bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue2023-01-21 → 2023-10-20¥20.6bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-10-20¥20.6bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-10-20¥694m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2023-01-21 → 2023-10-20¥9.9bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2023-01-21 → 2023-10-20¥9.7bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2023-01-21 → 2023-10-20¥280m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2023-01-21 → 2023-10-20¥397m
—segment totalrevenue2023-01-21 → 2023-10-20¥165.6bn
—segment totalrevenue external2023-01-21 → 2023-10-20¥165.3bn
—segment totalrevenue intersegment2023-01-21 → 2023-10-20¥313m
—segment totalsegment profit2023-01-21 → 2023-10-20¥6.8bn
Reconciling Itemsreconcilingrevenue2022-01-21 → 2022-10-20−¥521m
Reconciling Itemsreconcilingrevenue intersegment2022-01-21 → 2022-10-20−¥521m
Reconciling Itemsreconcilingsegment profit2022-01-21 → 2022-10-20−¥1.0bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥83.6bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥83.5bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥24m
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥2.8bn
jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segmentsegment profit2022-01-21 → 2022-10-20−¥380m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥16.4bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥16.4bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥6m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥1.3bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥15.5bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥15.5bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-10-20−¥752m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥9.7bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥9.2bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥490m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥377m
—segment totalrevenue2022-01-21 → 2022-10-20¥125.2bn
—segment totalrevenue external2022-01-21 → 2022-10-20¥124.6bn
—segment totalrevenue intersegment2022-01-21 → 2022-10-20¥521m
—segment totalsegment profit2022-01-21 → 2022-10-20¥3.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 397
ItemContextValueUnit
Deferred gains or losses on hedgesCurrentQuarterInstant786000000JPY
Foreign currency translation adjustmentPrior1YearInstant-8076000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant-7096000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-190000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-240000000JPY
Valuation and translation adjustmentsPrior1YearInstant-1375000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-1347000000JPY
Non controlling interestsPrior1YearInstant476000000JPY
Non controlling interestsCurrentQuarterInstant2068000000JPY
Net assetsPrior1YearInstant84067000000JPY
Net assetsCurrentQuarterInstant90503000000JPY
Liabilities and net assetsPrior1YearInstant164204000000JPY
Liabilities and net assetsCurrentQuarterInstant185593000000JPY
Net salesPrior1YTDDuration124640000000JPY
Net salesCurrentYTDDuration165278000000JPY
Cost of salesPrior1YTDDuration67963000000JPY
Cost of salesCurrentYTDDuration88651000000JPY
Gross profitPrior1YTDDuration56676000000JPY
Gross profitCurrentYTDDuration76626000000JPY
Selling general and administrative expensesPrior1YTDDuration54350000000JPY
Selling general and administrative expensesCurrentYTDDuration70834000000JPY
Operating incomePrior1YTDDuration2326000000JPY
Operating incomeCurrentYTDDuration5792000000JPY
Interest income noiPrior1YTDDuration73000000JPY
Interest income noiCurrentYTDDuration232000000JPY
Dividends income noiPrior1YTDDuration590000000JPY
Dividends income noiCurrentYTDDuration275000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration23000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration22000000JPY
Gain on the net monetary position noiPrior1YTDDuration-JPY
Gain on the net monetary position noiCurrentYTDDuration209000000JPY
Other noiPrior1YTDDuration407000000JPY
Other noiCurrentYTDDuration632000000JPY
Non operating incomePrior1YTDDuration1095000000JPY
Non operating incomeCurrentYTDDuration1372000000JPY
Interest expenses noePrior1YTDDuration168000000JPY
Interest expenses noeCurrentYTDDuration484000000JPY
Foreign exchange losses noePrior1YTDDuration124000000JPY
Foreign exchange losses noeCurrentYTDDuration1053000000JPY
Loss on the net monetary position noePrior1YTDDuration353000000JPY
Loss on the net monetary position noeCurrentYTDDuration-JPY
Other noePrior1YTDDuration171000000JPY
Other noeCurrentYTDDuration380000000JPY
Non operating expensesPrior1YTDDuration818000000JPY
Non operating expensesCurrentYTDDuration1917000000JPY
Ordinary incomePrior1YTDDuration2603000000JPY
Ordinary incomeCurrentYTDDuration5246000000JPY
Gain on sales of investment securities eiPrior1YTDDuration455000000JPY
Gain on sales of investment securities eiCurrentYTDDuration2025000000JPY
Insurance proceeds income eiPrior1YTDDuration-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-01-20pass
balance sheet identityconsolidated 2023-10-20pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-01-20pass
statement vs summary · net assetsconsolidated 2023-10-20pass
statement vs summary · net income attributable to parentconsolidated 2022-01-21/2022-10-20pass
statement vs summary · net income attributable to parentconsolidated 2023-01-21/2023-10-20pass
statement vs summary · revenueconsolidated 2022-01-21/2022-10-20pass
statement vs summary · revenueconsolidated 2023-01-21/2023-10-20pass
statement vs summary · total assetsconsolidated 2023-01-20pass
statement vs summary · total assetsconsolidated 2023-10-20pass